نتائج البحث - "Linda Pot"

المصدر: Journal for immunotherapy of cancer, 8(2):000938. BMC
Journal for Immunotherapy of Cancer
Journal for ImmunoTherapy of Cancer, Vol 8, Iss 2 (2020)

مصطلحات موضوعية: 0301 basic medicine, Cancer Research, Biodistribution, TRACERS, Immunology, Spleen, Pembrolizumab, 03 medical and health sciences, 0302 clinical medicine, PD-1 CHECKPOINT EXPRESSION, medicine, Immunology and Allergy, RC254-282, T-lymphocytes, Clinical/Translational Cancer Immunotherapy, Pharmacology, business.industry, Melanoma, Neoplasms. Tumors. Oncology. Including cancer and carcinogens, MURINE MODEL, medicine.disease, TUMORS, 030104 developmental biology, Lymphatic system, medicine.anatomical_structure, ANTIBODY, Oncology, tumor biomarkers, 030220 oncology & carcinogenesis, Cancer research, Molecular Medicine, immunotherapy, RADIOTRACER, Lymph, Bone marrow, business, Ex vivo, IMMUNO-PET

وصف الملف: application/pdf

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4afb92819fdcebab91dc21a9b7537909
https://doi.org/10.1136/jitc-2020-000938

Find this article in full text from ProQuest

5

Imaging the distribution of an antibody-drug conjugate constituent targeting mesothelin with Zr-89 and IRDye 800CW in mice bearing human pancreatic tumor xenografts

المؤلفون: Jos G. W. Kosterink, Eva J. ter Weele, Anton G.T. Terwisscha van Scheltinga, Silke R. Vedelaar, Elisabeth G.E. de Vries, Linda Pot, Marjolijn N. Lub-de Hooge, Laetitia E. Lamberts, Simon Williams

المساهمون: Guided Treatment in Optimal Selected Cancer Patients (GUTS), Biopharmaceuticals, Discovery, Design and Delivery (BDDD), Targeted Gynaecologic Oncology (TARGON), Molecular Systems Biology

المصدر: Oncotarget, 6(39), 42081-42090. Impact Journals LLC

وصف الملف: application/pdf

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5ab4bc984656d0cdcdf389a1a888588c
https://doi.org/10.18632/oncotarget.5877

6

ImmunoPET and biodistribution with human epidermal growth factor receptor 3 targeting antibody Zr-89-RG7116

المؤلفون: Gabriele Hölzlwimmer, Carolien P. Schröder, Marlene Thomas, Thomas Friess, Keelara Abiraj, Jos G. W. Kosterink, Elisabeth G.E. de Vries, Birgit Bossenmaier, Anton G.T. Terwisscha van Scheltinga, Marjolijn N. Lub-de Hooge, Linda Pot

المساهمون: Guided Treatment in Optimal Selected Cancer Patients (GUTS), Biopharmaceuticals, Discovery, Design and Delivery (BDDD), Targeted Gynaecologic Oncology (TARGON)

المصدر: mAbs, 6(4), 1051-1058
mAbs

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5f96ff2542f83b955191a11667194cf5
https://research.rug.nl/en/publications/0862af4c-4ef5-4a92-9e89-b28fe4ae19d4

PDF full text from Publisher

7

Measurement of Tumor VEGF-A Levels with Zr-89-Bevacizumab PET as an Early Biomarker for the Antiangiogenic Effect of Everolimus Treatment in an Ovarian Cancer Xenograft Model

المؤلفون: Linda Pot, Anton G.T. Terwisscha van Scheltinga, Jos G. W. Kosterink, Arne R.M. van der Bilt, Elisabeth G.E. de Vries, Carolien P. Schröder, Steven de Jong, Marjolijn N. Lub-de Hooge, Hetty Timmer-Bosscha, Anna K.L. Reyners, Ate G.J. van der Zee

المساهمون: Guided Treatment in Optimal Selected Cancer Patients (GUTS), Biopharmaceuticals, Discovery, Design and Delivery (BDDD), Targeted Gynaecologic Oncology (TARGON)

المصدر: Clinical Cancer Research, 18(22), 6306-6314. AMER ASSOC CANCER RESEARCH

مصطلحات موضوعية: Male, Vascular Endothelial Growth Factor A, EPITHELIAL OVARIAN, Cancer Research, Biodistribution, Bevacizumab, Mice, Nude, Standardized uptake value, Angiogenesis Inhibitors, Pharmacology, Antibodies, Monoclonal, Humanized, Mice, RADIOLABELED BEVACIZUMAB, Cell Line, Tumor, Biomarkers, Tumor, Medicine, Animals, Humans, RAD001 EVEROLIMUS, Everolimus, IN-VIVO, INDUCED APOPTOSIS, Ovarian Neoplasms, Radioisotopes, Sirolimus, Mice, Inbred BALB C, business.industry, TOR Serine-Threonine Kinases, Cancer, MOUSE MODEL, CELL CARCINOMA, medicine.disease, Xenograft Model Antitumor Assays, MTOR INHIBITOR EVEROLIMUS, Oncology, MAMMALIAN TARGET, Positron-Emission Tomography, Cancer cell, Cancer research, Female, Zirconium, Radiopharmaceuticals, business, Ovarian cancer, RAPAMYCIN, Ex vivo, medicine.drug

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::32c1ce600c230b565d8fc0622b25ab82
https://doi.org/10.1158/1078-0432.ccr-12-0406

8

Imaging the distribution of an antibody-drug conjugate constituent targeting mesothelin with ⁸⁹Zr and IRDye 800CW in mice bearing human pancreatic tumor xenografts

المؤلفون: Eva J, ter Weele, Anton G T, Terwisscha van Scheltinga, Jos G W, Kosterink, Linda, Pot, Silke R, Vedelaar, Laetitia E, Lamberts, Simon P, Williams, Marjolijn N, Lub-de Hooge, Elisabeth G E, de Vries

المصدر: Oncotarget

URL الوصول: https://explore.openaire.eu/search/publication?articleId=pmid________::1a411c31cff09eb37f9a552fdc2cccdd
https://pubmed.ncbi.nlm.nih.gov/26536664

9

ImmunoPET and biodistribution with human epidermal growth factor receptor 3 targeting antibody ⁸⁹Zr-RG7116

المؤلفون: Anton G T, Terwisscha van Scheltinga, Marjolijn N, Lub-de Hooge, Keelara, Abiraj, Carolien P, Schröder, Linda, Pot, Birgit, Bossenmaier, Marlene, Thomas, Gabriele, Hölzlwimmer, Thomas, Friess, Jos G W, Kosterink, Elisabeth G E, de Vries

المصدر: mAbs. 6(4)

مصطلحات موضوعية: Immunoconjugates, Receptor, ErbB-3, Mice, SCID, Radiography, Antibodies, Monoclonal, Murine-Derived, Mice, Isotopes, Neoplasms, Positron-Emission Tomography, Report, Animals, Heterografts, Humans, Zirconium, Radiopharmaceuticals, Neoplasm Transplantation

URL الوصول: https://explore.openaire.eu/search/publication?articleId=pmid________::40d3d6fd28f22d892348fd5eaab950ab
https://pubmed.ncbi.nlm.nih.gov/24870719

PDF full text from Publisher

10

Visualising dual downregulation of insulin-like growth factor receptor-1 and vascular endothelial growth factor-A by heat shock protein 90 inhibition effect in triple negative breast cancer

المؤلفون: Jos G. W. Kosterink, Anton G.T. Terwisscha van Scheltinga, Elisabeth G.E. de Vries, Hilde H. Nienhuis, Marjolijn N. Lub-de Hooge, Linda Pot, Hetty Timmer-Bosscha, Sietske B. M. Gaykema, Carolien P. Schröder, Paul Berghuis

المساهمون: Guided Treatment in Optimal Selected Cancer Patients (GUTS), Biopharmaceuticals, Discovery, Design and Delivery (BDDD), Targeted Gynaecologic Oncology (TARGON)

المصدر: European Journal of Cancer, 50(14), 2508-2516. ELSEVIER SCI LTD
European Journal of Cancer

مصطلحات موضوعية: ZR-89-TRASTUZUMAB, Male, Vascular Endothelial Growth Factor A, Cancer Research, medicine.medical_treatment, HSP90 INHIBITOR, Triple Negative Breast Neoplasms, VEGF-A, Hsp90 inhibitor, Receptor, IGF Type 1, Mice, NVP-AUY922, Triple negative breast cancer, Triple-negative breast cancer, Mice, Inbred BALB C, Chemistry, SOLID TUMORS, 3. Good health, Vascular endothelial growth factor A, PHASE-I, Oncology, MCF-7 Cells, Female, EXPRESSION, Hsp90 inhibition, medicine.medical_specialty, Down-Regulation, Downregulation and upregulation, In vivo, HEAT-SHOCK-PROTEIN-90 INHIBITOR, Heat shock protein, Internal medicine, medicine, Animals, Humans, HSP90 Heat-Shock Proteins, TUMOR XENOGRAFT, Growth factor, Biomarker, Zirconium-89, Isoxazoles, Resorcinols, DEGRADATION, Xenograft Model Antitumor Assays, PET, Endocrinology, METASTASIS, Cancer research, IGF-1R, Ex vivo

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::dfab8abd9d5d30dbc277b96761c6fc99
https://pubmed.ncbi.nlm.nih.gov/25027745

View record from ScienceDirect

Full Text via ClinicalKey

تنقيح النتائج